Pharmaceutical Industry Information Portal

HomeTagsCitagenix

All posts by tag

Citagenix

Antibe Therapeutics, a $6.5 million strategic sale to a subsidiary of Citagenix

Antibe Therapeutics Inc., a clinical stage company leveraging its hydrogen sulfide platform to develop next-generation safer therapies that target inflammation announced to sell its...
spot_img

Expert Articles

spot_img